2 completed, 1 terminated. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Terminated 1 |
Follow Body Dysmorphic Disorders: new trials by email Literature Review of Body Dysmorphic Disorders trials Research Report on Body Dysmorphic Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CBT as an Adjunct to SRIs in the Treatment of BDD Cognitive Behavioral Therapy, Venlafaxine - Body Dysmorphic Disorder | Phase 4 | Terminated | Icahn School of Medicine at Mount Sinai | 17 | 2008-09-01 | 2017-03-09 |
| Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder Levetiracetam - Body Dysmorphic Disorder | Phase 4 | Completed | Butler Hospital | 17 | 2004-12-01 | 2019-08-29 |
| Fluoxetine in Pediatric Body Dysmorphic Disorder Fluoxetine, Placebo - Body Dysmorphic Disorder | Phase 4 | Completed | Montefiore Medical Center | 43 | 2004-11-01 | 2018-04-27 |
Mental Disorders (3) · Somatoform Disorders (3)
Cognitive Behavioral Therapy (1) · Fluoxetine (1) · Levetiracetam (1) · Venlafaxine Hydrochloride (1)
Butler Hospital (1) · Icahn School of Medicine at Mount Sinai (1) · Montefiore Medical Center (1)
United States (3)
Eric Hollander, MD (2) · Andrea Allen, PhD (1) · Katharine A Phillips, M.D. (1)